Structure-Activity Relationship of Ionizable Lipids for siRNA and mRNA Lipid Nanoparticle Design

被引:0
作者
Lee, Sang M. [1 ]
Sun, Yehui [1 ]
Chatterjee, Sumanta [1 ]
Xiong, Hu [1 ]
Cheng, Qiang [1 ]
Wang, Xu [1 ]
Siegwart, Daniel J. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr, Simmons Comprehens Canc Ctr, Program Genet Drug Engn, Dept Biomed Engn,Dept Biochem, Dallas, TX 75235 USA
基金
美国国家卫生研究院;
关键词
lipid nanoparticle; siRNA; mRNA; hepaticdelivery; ionizable lipid;
D O I
10.1021/acsbiomaterials.5c00463
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Lipid nanoparticles (LNPs) represent the most effective vehicle class identified to date for delivering RNA. A stronger understanding of the structure-activity relationships that govern successful mRNA delivery would enable the development of improved LNPs. Herein, ionizable lipids with high mRNA in vitro delivery efficacy among 465 lipids were selected to be evaluated for their in vivo activity and structure-activity relationship. Variations of these ionizable amino hydroxy and amino lipid families were synthesized, and 42 lipids were evaluated to study how chemical alterations of the carbon chain within the core influence LNP potency. To further understand the relationship between chemical structure and in vivo hepatic delivery potency, physicochemical properties including size, PDI, pK a, and buffering capacity were measured. Our evaluations revealed that both the pK a and buffering capacity may be valuable in predicting in vivo hepatic delivery based on lipid structures, expanding the range of acceptable LNP pK a to 6.2-7.4, and showed that the buffering capacity may help predict formulations for successful hepatic delivery of mRNA-LNPs. This study reiterates the importance of the chemical structure of the ionizable amino lipid for LNPs and highlights the intricacies of its relationship with the physical properties of LNPs. We anticipate that understanding the structure-activity relationship of ionizable lipids will be valuable for the continued rational design of ionizable amino lipids for the LNP delivery of small and large RNA cargoes.
引用
收藏
页数:9
相关论文
共 30 条
[1]   The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs [J].
Akinc, Akin ;
Maier, Martin A. ;
Manoharan, Muthiah ;
Fitzgerald, Kevin ;
Jayaraman, Muthusamy ;
Barros, Scott ;
Ansell, Steven ;
Du, Xinyao ;
Hope, Michael J. ;
Madden, Thomas D. ;
Mui, Barbara L. ;
Semple, Sean C. ;
Tam, Ying K. ;
Ciufolini, Marco ;
Witzigmann, Dominik ;
Kulkarni, Jayesh A. ;
van der Meel, Roy ;
Cullis, Pieter R. .
NATURE NANOTECHNOLOGY, 2019, 14 (12) :1084-1087
[2]   The role of lipid components in lipid nanoparticles for vaccines and gene therapy [J].
Albertsen, Camilla Hald ;
Kulkarni, Jayesh A. ;
Witzigmann, Dominik ;
Lind, Marianne ;
Petersson, Karsten ;
Simonsen, Jens B. .
ADVANCED DRUG DELIVERY REVIEWS, 2022, 188
[3]   The clinical progress of mRNA vaccines and immunotherapies [J].
Barbier, Ann J. ;
Jiang, Allen Yujie ;
Zhang, Peng ;
Wooster, Richard ;
Anderson, Daniel G. .
NATURE BIOTECHNOLOGY, 2022, 40 (06) :840-854
[4]   mRNA vaccines for infectious diseases: principles, delivery and clinical translation [J].
Chaudhary, Namit ;
Weissman, Drew ;
Whitehead, Kathryn A. .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (11) :817-838
[5]   In situ production and secretion of proteins endow therapeutic benefit against psoriasiform dermatitis and melanoma [J].
Cheng, Qiang ;
Farbiak, Lukas ;
Vaidya, Amogh ;
Guerrero, Erick ;
Lee, Eunice E. ;
Rose, Elysha K. ;
Wang, Xu ;
Robinson, Joshua ;
Lee, Sang M. ;
Wei, Tuo ;
Miller, William E. ;
Benedicto, Ester Alvarez ;
Lian, Xizhen ;
Wang, Richard C. ;
Siegwart, Daniel J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (52)
[6]   Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing [J].
Cheng, Qiang ;
Wei, Tuo ;
Farbiak, Lukas ;
Johnson, Lindsay T. ;
Dilliard, Sean A. ;
Siegwart, Daniel J. .
NATURE NANOTECHNOLOGY, 2020, 15 (04) :313-+
[7]   Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I [J].
Cheng, Qiang ;
Wei, Tuo ;
Jia, Yuemeng ;
Farbiak, Lukas ;
Zhou, Kejin ;
Zhang, Shuyuan ;
Wei, Yonglong ;
Zhu, Hao ;
Siegwart, Daniel J. .
ADVANCED MATERIALS, 2018, 30 (52)
[8]   Discovery of a Novel Amino Lipid That Improves Lipid Nanoparticle Performance through Specific Interactions with mRNA [J].
Cornebise, Mark ;
Narayanan, Elisabeth ;
Xia, Yan ;
Acosta, Edward ;
Ci, Lei ;
Koch, Hillary ;
Milton, Jaclyn ;
Sabnis, Staci ;
Salerno, Timothy ;
Benenato, Kerry E. .
ADVANCED FUNCTIONAL MATERIALS, 2022, 32 (08)
[9]   Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs [J].
Dilliard, Sean A. ;
Siegwart, Daniel J. .
NATURE REVIEWS MATERIALS, 2023, 8 (04) :282-300
[10]   On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles [J].
Dilliard, Sean A. ;
Cheng, Qiang ;
Siegwart, Daniel J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (52)